Assessment of Radiation-Induced Optic Neuropathy in a Multi-Institutional Cohort of Chordoma and Chondrosarcoma Patients Treated with Proton Therapy - Sorbonne Université
Journal Articles Cancers Year : 2021

Assessment of Radiation-Induced Optic Neuropathy in a Multi-Institutional Cohort of Chordoma and Chondrosarcoma Patients Treated with Proton Therapy

Abstract

Radiation-induced optic neuropathy (RION) is a rare side effect following radiation therapy involving the optic structures whose onset is, due to the low amount of available data, challenging to predict. We have analyzed a multi-institutional cohort including 289 skull-base cancer patients treated with proton therapy who all received >45 GyRBE to the optic apparatus. An overall incidence rate of 4.2% (12) was observed, with chordoma patients being at higher risk (5.8%) than chondrosarcoma patients (3.2%). Older age and arterial hypertension, tumor involvement, and repeated surgeries (>3) were found to be associated with RION. Based on bootstrapping and cross-validation, a NTCP model based on age and hypertension was determined to be the most robust, showing good classification ability (AUC-ROC 0.77) and calibration on our dataset. We suggest the application of this model with a threshold of 6% to segment patients into low and high-risk groups before treatment planning. However, further data and external validation are warranted before clinical application.
Fichier principal
Vignette du fichier
cancers-13-05327-v2.pdf (1.26 Mo) Télécharger le fichier
Origin Publication funded by an institution

Dates and versions

hal-03442907 , version 1 (23-11-2021)

Identifiers

Cite

Andreas Köthe, Loïc Feuvret, Damien Charles Weber, Sairos Safai, Antony John Lomax, et al.. Assessment of Radiation-Induced Optic Neuropathy in a Multi-Institutional Cohort of Chordoma and Chondrosarcoma Patients Treated with Proton Therapy. Cancers, 2021, 13 (21), pp.5327. ⟨10.3390/cancers13215327⟩. ⟨hal-03442907⟩
50 View
28 Download

Altmetric

Share

More